These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23446484)
1. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance]. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484 [TBL] [Abstract][Full Text] [Related]
2. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of TESTIN in primary gastric cancer]. Huang W; Weng DS; Pan ZZ; Pan K; Ding PR; Zhou J; Wang H; Zhang HK; Li JJ; Xia JC Ai Zheng; 2008 Sep; 27(9):984-8. PubMed ID: 18799041 [TBL] [Abstract][Full Text] [Related]
4. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025 [TBL] [Abstract][Full Text] [Related]
5. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
7. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma. Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591 [TBL] [Abstract][Full Text] [Related]
8. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance]. Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532 [TBL] [Abstract][Full Text] [Related]
9. Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10. Morikawa Y; Kezuka C; Endo S; Ikari A; Soda M; Yamamura K; Toyooka N; El-Kabbani O; Hara A; Matsunaga T Chem Biol Interact; 2015 Mar; 230():30-9. PubMed ID: 25686905 [TBL] [Abstract][Full Text] [Related]
10. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis. Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer]. Zhuge YH; Tao HQ; Wang YY Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2765-8. PubMed ID: 22322056 [TBL] [Abstract][Full Text] [Related]
12. Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue. Hevir N; Sinkovec J; Lanišnik Rižner T Chem Biol Interact; 2013 Feb; 202(1-3):226-33. PubMed ID: 23146748 [TBL] [Abstract][Full Text] [Related]
13. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer. Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539 [TBL] [Abstract][Full Text] [Related]
14. [Expression of osteopontin mRNA and its clinical significance in gastric cancer]. Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323 [TBL] [Abstract][Full Text] [Related]
15. Loss expression of PHLPP1 correlates with lymph node metastasis and exhibits a poor prognosis in patients with gastric cancer. Wang Z; Shu H; Wang Z; Li G; Cui J; Wu H; Cai S; He W; He Y; Zhan W J Surg Oncol; 2013 Dec; 108(7):427-32. PubMed ID: 24037758 [TBL] [Abstract][Full Text] [Related]
16. [Expression of CCAAT/enhancer binding protein beta in human gastric carcinoma and its clinical significance]. Du YX; Zhang LH; Wang XH; Xing XF; Cheng XJ; Du H; Hu Y; Li YA; Zhu YB; Jia YN; Lin Y; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):179-82. PubMed ID: 23446483 [TBL] [Abstract][Full Text] [Related]
17. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898 [TBL] [Abstract][Full Text] [Related]
18. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer]. Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma]. Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498 [TBL] [Abstract][Full Text] [Related]
20. Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Wang B; Li GX; Zhang SG; Wang Q; Wen YG; Tang HM; Zhou CZ; Xing AY; Fan JW; Yan DW; Qiu GQ; Yu ZH; Peng ZH Exp Biol Med (Maywood); 2011 Nov; 236(11):1247-53. PubMed ID: 21998129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]